Abstract
The fight against osteosarcoma presents a series of considerable challenges, consolidating it as one of the most frequent oncological manifestations, especially among the pediatric and adolescent segment. The incidence of this disease is high, with around a quarter of patients receiving the diagnosis already in the metastatic phase. Additionally, the complications inherent to the treatmen…